Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Phase II evaluation of the sulfonylurea LY186,641 in men with hormone independent metastatic prostate cancer.

× No keyword cloud information.

5 in total

1. Cancer statistics, 1991.

Authors: C C Boring; T S Squires; T Tong
Journal: CA Cancer J Clin Date: 1991 Jan-Feb Impact factor: 508.702

2. Clinical pharmacology of a novel diarylsulfonylurea anticancer agent.

Authors: C W Taylor; D S Alberts; M A Ketcham; W G Satterlee; M T Holdsworth; P M Plezia; Y M Peng; T M McCloskey; D J Roe; M Hamilton
Journal: J Clin Oncol Date: 1989-11 Impact factor: 44.544

3. Effect of antitumor diarylsulfonylureas on in vivo and in vitro mitochondrial structure and functions.

Authors: J H Thakar; C Chapin; R H Berg; R A Ashmun; P J Houghton
Journal: Cancer Res Date: 1991-12-01 Impact factor: 12.701

4. Inhibition of PAIII rat prostatic adenocarcinoma growth and metastasis by a new diarylsulfonylurea antitumor agent, LY181984.

Authors: B L Neubauer; R L Merriman; K L Best; R L Goode; M F Sarosdy; L R Tanzer; J J Howbert
Journal: J Urol Date: 1992-02 Impact factor: 7.450

5. Phase I clinical study of N-[(4-chlorophenyl)amino]carbonyl-2,3-dihydro-1H-indene-5-sulfonamide (LY186641).

Authors: J D Hainsworth; K R Hande; W G Satterlee; J Kuttesch; D H Johnson; G Grindey; L E Jackson; F A Greco
Journal: Cancer Res Date: 1989-09-15 Impact factor: 12.701

5 in total

1 in total

1. A phase I study of sulofenur in refractory pediatric malignant solid tumors.

Authors: C B Pratt; L C Bowman; N Marina; A Pappo; L Avery; X Luo; W H Meyer
Journal: Invest New Drugs Date: 1995 Impact factor: 3.850

1 in total